Results 21 to 30 of about 2,708,416 (288)
Background The Choosing Wisely campaign has spread to many countries. Methods for developing recommendations are inconsistent. We describe our process of developing such recommendations from a comprehensive national set of clinical practice guidelines ...
Raija Sipilä+2 more
doaj +1 more source
Success in peritoneal dialysis (PD) requires a well-functioning catheter, and catheter placement at PD initiation is extremely important for long-term PD.
Tsutomu Sakurada+9 more
doaj +1 more source
Background Diabetes has become the most common cause of end-stage renal disease (ESRD) requiring renal replacement therapy (RRT) in most countries around the world.
Yukio Maruyama+9 more
doaj +1 more source
Background Pediatric lead exposure in the United States (U.S.) remains a preventable public health crisis. Shareable electronic clinical decision support (CDS) could improve lead screening and management. However, discrepancies between federal, state and
Jeremy J. Michel+2 more
doaj +1 more source
The close interaction between hypoxia-related proteins and metastasis in pancarcinomas
Many primary-tumor subregions exhibit low levels of molecular oxygen and restricted access to nutrients due to poor vascularization in the tissue, phenomenon known as hypoxia.
Andrés López-Cortés+17 more
doaj +1 more source
Core outcome sets through the healthcare ecosystem: the case of type 2 diabetes mellitus
Background It is increasingly accepted that insufficient attention has been given to the patient health outcomes that are important to measure in comparative effectiveness research that will inform decision-making.
Susanna Dodd+5 more
doaj +1 more source
Ivermectin treatment for Strongyloides infection in patients with COVID-19
Ivermectin, an antiparasitic agent, is not recommended for prophylaxis or treatment of coronavirus disease 2019 (COVID-19). Inappropriate use of ivermectin for treatment of COVID-19 may make it less available for patients with serious parasitic ...
Elizabeth Leung+12 more
doaj +1 more source
Traitement à l’ivermectine pour l’infection à Strongyloides chez les patients atteints de COVID-19
L’ivermectine, un agent antiparasitaire, n’est pas recommandé pour la prophylaxie ou le traitement de la maladie à coronavirus 2019 (COVID-19).
Elizabeth Leung+12 more
doaj +1 more source
Molecular Pathogenesis and New Therapeutic Dimensions for Spinal Muscular Atrophy
The condition known as 5q spinal muscular atrophy (SMA) is a devastating autosomal recessive neuromuscular disease caused by a deficiency of the ubiquitous protein survival of motor neuron (SMN), which is encoded by the SMN1 and SMN2 genes.
Andrés López-Cortés+2 more
doaj +1 more source